Contra-indicated in patients with complete biliary obstruction.
- Trade Names: Chol-Less; Colestrol; Lismol; PMS-Cholestyramine; Prevalite; Quantalan; Questran (Par); Questran Lite
- Indications: Pruritus associated with biliary obstruction, primary hypercholesterolemia
- Class: Bile acid sequestrant
- Half-life: N/A
- Clinically important, potentially hazardous interactions with:
Acarbose, Acetaminophen, Acitretin, Amiodarone, Aspirin, Bezafibrate, Calcifediol, Chloroquine, Cyclopenthiazide, Cyclosporine, Deferasirox, Digoxin, Doxepin, Doxercalciferol, Ergocalciferol, Ezetimibe, Ezetimibe, Hydroxychloroquine, Isotretinoin, Leflunomide, Levodopa, Lovastatin, Meloxicam, Mycophenolate, Phytonadione, Propranolol, Raloxifene, Sulfasalazine, Sulfonylureas, Tetracycline, Tricyclic antidepressants, Troglitazone, Ursodiol, Valproic Acid, Vitamin A, Vitamin E
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 03/01/2026
